DNM2 and cancer: Growing evidence show that fibroblast mediated ECM-degradation might be necessary to pave the way for cancer cells to modify, proliferate and undergo metastatic invasions64 via a set of matrix metalloproteinases (MMPs) and downregulation of Dyn2, but the mechanisms underlying the fibroblast mediated ECM degradation largely remain unknown.65